levorphanol and Retinal-Diseases

levorphanol has been researched along with Retinal-Diseases* in 1 studies

Other Studies

1 other study(ies) available for levorphanol and Retinal-Diseases

Article	Year
Dextromethorphan protects retina against ischemic injury in vivo. Archives of ophthalmology (Chicago, Ill. : 1960), 1989, Volume: 107, Issue:3 Retinal ischemia was induced in rabbits by increasing intraocular pressure above systolic blood pressure for 60 or 75 minutes, and retinal function was monitored by electroretinography. Pretreatment with intravenous dextromethorphan, a nonprescription antitussive and selective antagonist of N-methyl-D-aspartate receptors, enhanced greatly the post-ischemic recovery of b-wave amplitude. Dextromethorphan may prove to be useful clinically in the management of retinal ischemic disease. Topics: Animals; Dextromethorphan; Electroretinography; Infusions, Intravenous; Ischemia; Levorphanol; Rabbits; Retina; Retinal Diseases; Retinal Vessels; Time Factors	1989

Article

Year

Dextromethorphan protects retina against ischemic injury in vivo.

Archives of ophthalmology (Chicago, Ill. : 1960), 1989, Volume: 107, Issue:3

Retinal ischemia was induced in rabbits by increasing intraocular pressure above systolic blood pressure for 60 or 75 minutes, and retinal function was monitored by electroretinography. Pretreatment with intravenous dextromethorphan, a nonprescription antitussive and selective antagonist of N-methyl-D-aspartate receptors, enhanced greatly the post-ischemic recovery of b-wave amplitude. Dextromethorphan may prove to be useful clinically in the management of retinal ischemic disease.

Topics: Animals; Dextromethorphan; Electroretinography; Infusions, Intravenous; Ischemia; Levorphanol; Rabbits; Retina; Retinal Diseases; Retinal Vessels; Time Factors

1989